Showing results (5271-5280 of 5,703) with videos related to

Sort By:
Pageof 571
The Oncologist|April 2, 2020
Lack of Association Between Radiographic Tumor Burden and Efficacy of Immune Checkpoint Inhibitors in Advanced Lung CancerVinita Popat, Rong Lu, Murtaza Ahmed, et al.
The Oncologist|November 28, 2018
Systemic Therapy Use and Outcomes After Relapse from Preoperative Radiation and Extrapleural Pneumonectomy for Malignant Pleural MesotheliomaSara V Soldera, John Kavanagh, Melania Pintilie, et al.
The Oncologist|November 28, 2018
Phase I, First-in-Human, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Vorolanib in Patients with Advanced Solid TumorsJohanna C Bendell, Manish R Patel, Kathleen N Moore, et al.
The Oncologist|November 29, 2018
Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Neurologic Toxicity: Illustrative Case and Review of the LiteratureKerry L Reynolds, Amanda C Guidon
The Oncologist|January 18, 2019
S-1 plus Raltitrexed for Refractory Metastatic Colorectal Cancer: A Phase II TrialYe Chen, Jing Wu, Ke Cheng, et al.
The Oncologist|January 18, 2019
Exploring Biomarkers of Phosphoinositide 3-Kinase Pathway Activation in the Treatment of Hormone Receptor Positive, Human Epidermal Growth Receptor 2 Negative Advanced Breast CancerVirginia G Kaklamani, Andrea L Richardson, Carlos L Arteaga
The Oncologist|November 27, 2020
Phase I Dose-Escalation Study of SCB01A, a Microtubule Inhibitor with Vascular Disrupting Activity, in Patients with Advanced Solid TumorsHer-Shyong Shiah, Nai-Jung Chiang, Chia-Chi Lin, et al.
The Oncologist|November 24, 2020
Everolimus Plus Exemestane Treatment in Patients with Metastatic Hormone Receptor-Positive Breast Cancer Previously Treated with CDK4/6 Inhibitor TherapyMadeline M Cook, Luai Al Rabadi, Andy J Kaempf, et al.
The Oncologist|November 24, 2020
Wild-type APC Is Associated with Poor Survival in Metastatic Microsatellite Stable Colorectal CancerChongkai Wang, Ching Ouyang, May Cho, et al.
The Oncologist|February 14, 2018
FDA Approval Summary: Lenalidomide as Maintenance Therapy After Autologous Stem Cell Transplant in Newly Diagnosed Multiple MyelomaElizabeth Dianne Pulte, Andrew Dmytrijuk, Lei Nie, et al.
Pageof 571